ArticleFrontiers in oncology2022

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer.

Jharna Datta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.